MISSION STATEMENT: The HIV+Hepatitis Policy Institute promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.
Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.
Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.
Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.
Executive Director, HIV+Hepatitis Policy Institute, Washington, D.C.
Carl Schmid has been a national policy and advocacy leader in the HIV community for over 20 years. He spent 16 years with The AIDS Institute, serving as its Deputy Executive Director. In December 2019, he formed the HIV+Hepatitis Policy Institute, which promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.
Mr. Schmid leads advocacy efforts to ensure domestic HIV and hepatitis programs are based on sound public policy and fully funded. He has expertise in healthcare financing systems, including Medicaid and Medicare, and leads efforts to ensure that the Affordable Care Act meets the needs of beneficiaries, including prescription medications.
From December 2018 to August 2021 he served as Co-Chair of the Presidential Advisory Council on HIV/AIDS (PACHA). He currently serves as a member of PACHA and Co-chairs the Ending the HIV Epidemic Subcommittee, as a consumer representative to the National Association of Insurance Commissioners, and as a member of the NAIC/Consumer Participation Board of Trustees.
He is a cancer survivor and living with chronic hepatitis B.
Mr. Schmid earned a B.A. in Public Affairs and an M.B.A. in International Affairs from the George Washington University in Washington, D.C.
Health Policy Manager
The Lefert Group
HIV+Hep Policy Institute
Senior Director, Government Affairs
Intra-Cellular Therapies, Inc.
Vice President, Head of Global Policy
Gilead Sciences, Inc.
Foster City, CA
JUSTIN C. SMITH MS, MPH
Director, Campaign to End AIDS
Positive Impact Health Centers
Associate Vice President of Federal Policy
Director of External Affairs
Oakland Park, FL
Senior Vice President
American Cancer Society
Cancer Action Network
STEVEN R. YOUNG
HIV/AIDS Bureau, HRSA, HHS
Funders for HIV+Hepatitis Policy Institute
HIV+Hep appreciates the support of numerous funders, and recognizes those below that are our corporate members and sponsors: